Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
12.79
-0.25 (-1.92%)
Nov 21, 2024, 4:00 PM EST - Market closed
Rocket Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,166 | 2,702 | 1,481 | 1,407 | 3,322 | 1,233 | |
| Market Cap Growth | -16.10% | 82.43% | 5.29% | -57.65% | 169.40% | 87.58% | |
| Enterprise Value | 979 | 2,290 | 1,197 | 1,008 | 3,162 | 1,039 | |
| Last Close Price | 13.04 | 29.97 | 19.57 | 21.83 | 54.84 | 22.76 | |
| PB Ratio | 3.60 | 5.49 | 3.02 | 3.09 | 6.60 | 4.01 | |
| P/TBV Ratio | 6.33 | 6.31 | 3.49 | 3.32 | 7.03 | 4.46 | |
| Debt / Equity Ratio | 0.08 | 0.05 | 0.05 | 0.05 | 0.12 | 0.15 | |
| Quick Ratio | 5.89 | 7.69 | 9.10 | 17.54 | 14.80 | 16.61 | |
| Current Ratio | 6.05 | 7.80 | 9.29 | 17.69 | 14.94 | 16.81 | |
| Return on Equity (ROE) | -59.27% | -50.01% | -46.98% | -35.29% | -34.46% | -30.83% | |
| Return on Assets (ROA) | -34.48% | -29.03% | -26.30% | -19.10% | -17.43% | -15.22% | |
| Return on Capital (ROIC) | -37.13% | -31.51% | -27.86% | -19.93% | -18.25% | -16.07% | |
| Earnings Yield | -21.27% | -9.09% | -14.98% | -12.02% | -4.21% | -6.27% | |
| FCF Yield | -16.68% | -7.82% | -12.59% | -9.15% | -2.87% | -7.13% | |
| Buyback Yield / Dilution | -17.60% | -23.27% | -7.77% | -14.18% | -13.00% | -24.46% | |
| Total Shareholder Return | -17.60% | -23.27% | -7.77% | -14.18% | -13.00% | -24.46% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.